RENAISSANCE TECHNOLOGIES LLC
Position in WHWK — Whitehawk Therapeutics, Inc.
CIK 1037389
NEW YORK, NY
Position in WHWK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,895,304
+$416,559 QoQ
Shares Held
413,822
-3.5% QoQ
Ownership
0.726%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 78 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in WHWK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. WHWK ranks #135 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in WHWK
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,895,304 | 413,822 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,478,745 | 428,622 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,066,547 | 440,722 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $869,101 | 457,422 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $856,875 | 458,222 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $822,577 | 462,122 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,438,749 | 456,022 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $951,353 | 461,822 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $641,264 | 439,222 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,272,309 | 543,722 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $805,418 | 398,722 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,190,262 | 245,922 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,396,194 | 204,122 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,358,241 | 325,724 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,223,178 | 251,222 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,446,617 | 243,922 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,137,791 | 173,522 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,367,688 | 139,522 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,103,806 | 128,522 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,865,287 | 165,655 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||